Statement: patients diagnosed with hormone receptor positive advanced breast cancer and who have previously undergone chemotherapy for this condition are qualified for the primary clinical trial
Primary_evidence: Inclusion Criteria:   Confirmed hormone receptor positive advanced breast cancer, postmenopausal women Exclusion Criteria:   Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).